Tailored HIV treatment aims for fewer side effects
NCT ID NCT03385473
Summary
This study tested if adjusting the dose of two common HIV drugs (efavirenz or atazanavir) based on a patient's genetics and drug levels in their blood could work as well as standard fixed doses, but with fewer side effects and better cost-effectiveness. It involved 190 adults in Argentina who were starting HIV treatment for the first time. Participants were randomly assigned to receive either the standard fixed dose or a personalized dose based on their test results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Italiano de Buenos Aires - Infectious Diseases Section
Buenos Aires, Buenos Aires F.D., 1181, Argentina
Conditions
Explore the condition pages connected to this study.